BPC-157

BPC-157 | Body Protection Compound-157 | Research Peptide

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula: C₆₂H₁₀₀N₁₆O₂₂ Molecular Weight: 1419.53 g/mol Purity: >99% (HPLC verified) Form: Lyophilised powder Available Sizes: 5mg | 10mg Storage: –20°C, away from light and moisture CAS Number: 137525-51-0

What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a partial sequence of Body Protection Compound, a protein naturally found in human gastric juice. First identified and isolated in the 1990s, BPC-157 has since become one of the most actively studied peptides in preclinical research, attracting significant scientific interest for its pleiotropic biological activity.

Our BPC-157 is produced under strict quality-controlled conditions, achieving a verified purity of greater than 99% as confirmed by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). It is supplied in lyophilised (freeze-dried) form to ensure maximum stability and shelf life.

Research Background & Scientific Interest

BPC-157 has been the subject of numerous peer-reviewed preclinical studies, the majority conducted in rodent models. Researchers across gastroenterology, orthopaedics, neuroscience, and pharmacology have explored the compound's interaction with multiple biological pathways.

Key areas of active research include:

Tissue and Wound Healing Preclinical studies have investigated BPC-157's influence on angiogenesis — the formation of new blood vessels — and fibroblast activity. Research published in peer-reviewed journals suggests the compound may interact with the nitric oxide (NO) system, which plays a central role in vascular regulation and tissue repair mechanisms.

Gastrointestinal Research Given its origin from gastric juice proteins, BPC-157 has drawn considerable attention in GI research. Animal studies have explored its effects on gastric ulcer models, inflammatory bowel conditions, and intestinal anastomosis healing, with researchers observing notable cytoprotective responses in mucosal tissue models.

Musculoskeletal & Tendon Models A growing body of preclinical literature has examined BPC-157 in models involving tendon, ligament, bone, and muscle tissue. Researchers have observed upregulation of growth hormone receptor expression in tendon fibroblast cell lines — a finding that has generated further mechanistic inquiry.

Neurological & Dopaminergic Pathways Some preclinical research has investigated BPC-157's interaction with dopaminergic and serotonergic systems, as well as its potential neuroprotective properties in brain lesion and traumatic injury models. These findings remain in early exploratory stages and warrant further rigorous study.

Anti-inflammatory Mechanisms BPC-157 has been studied in models of inflammation, with research suggesting modulation of inflammatory cytokine activity. Its interaction with the VEGFR2-Akt-eNOS signalling pathway is one proposed mechanism currently under investigation.

Product Specifications

Quality & Purity Assurance

Every batch of our BPC-157 undergoes rigorous third-party testing before release. Our quality assurance process includes:

• HPLC Analysis — confirms peptide purity exceeding 99%
• Mass Spectrometry (MS) — verifies molecular identity and sequence integrity
• Endotoxin Testing — ensures product is free from bacterial endotoxins
• Certificate of Analysis (CoA) — available for every batch upon request

We are committed to supplying researchers with the highest-grade peptides available on the market. Consistency, traceability, and transparency are central to our quality standards.

Handling & Reconstitution (Research Use)

BPC-157 lyophilised powder should be reconstituted using sterile bacteriostatic water or dilute acetic acid (0.1%) depending on the experimental protocol. Once reconstituted, the solution should be aliquoted and stored at –20°C to preserve stability and avoid repeated freeze-thaw cycles, which can degrade peptide integrity.

Researchers should handle all peptides in accordance with standard laboratory safety practices and applicable institutional guidelines.

Important Notice

This product is intended strictly for in vitro research and laboratory use only. BPC-157 is not approved for human or veterinary use by the FDA, EMA, or any other regulatory authority. It is not a drug, supplement, or food product. This product must not be administered to humans or animals. By purchasing this product, the buyer confirms they are a qualified researcher and will use the compound solely for lawful scientific research purposes.